Search Tag: Getinge
Getinge Awarded Most Sustainable Company in the Life Science Industry
2021 02 Jul
For the second time, as World Finance Magazine awards businesses across the world that are taking action to tackle climate change, Getinge was named winner in the category Most Sustainable Company in the Life Science Industry. As World Finance Magazine announced this year’s winners of their sustainability award, Getinge was recognized for... Read more
NAVA Mode In Adult Acute Respiratory Failure - First Installment
2021 27 Jan
Speaker Jesús Villar, MD, PhD There will be total of 4 webinars, Save the date for our other events: February 19 - NAVA: The Science, Management and implementation in the NICU. March 3 - Difficult weaning from the ventilator: NAVA is helpful. End of April ( TBD) - NAVA: Insights from RESTUS study. Find Ge Read more
Intensive Care Ventilators - A Primary Option For Treatment Of COVID-19 Patients In The ICU
2020 06 Nov
Summary & recommendations regarding ventilators Intensive care ventilators are normally found in the hospital Intensive Care Unit. This category of ventilators support lung protective ventilation recommended by several international guidelines and the World Health Organization (WHO). An intensive care ventilator must be considered as the... Read more
Getinge launches NICCI – the latest innovation in Advanced Hemodynamic Monitoring
2020 26 Oct
NICCI is Getinge’s latest innovation in Advanced Hemodynamic Monitoring, providing continuous and noninvasive hemodynamic insights to reduce the risk of severe complications for patients with low blood pressure. Blood pressure is one of the most important variables evaluated during almost every surgical intervention, but recent... Read more
Ventilator Training Alliance app receives awards and surpasses 60,000 downloads
2020 23 Oct
The Ventilator Training Alliance (VTA) app released earlier this year by Getinge and other major ventilator manufacturers now surpasses 60,000 downloads and receives innovation awards while continuing to support frontline medical workers during COVID-19. Earlier this year Getinge joined forces together with other ventilator manufacturers... Read more
Getinge Webinar - Pediatric and neonatal severe COVID-19 cases: the update
2020 29 Oct
Speakers Daniele De Luca MD, PhD - Chief, Division of Pediatrics, Dr. Miray Kärnekull Medical Affairs Director – ACT Dr. Mark Konrad Head of Medical Read more
Born Too Early With A 50/50 Chance Of Survival - Now She Helps Save Other Premature Babies
2020 06 Oct
When Sabina Checketts holds her hand a certain way, the tiny scar on the back of it looks like a rocket ship. Checketts got the scar during the first few days of her life, during a tenuous struggle for survival, after she was born at 28 weeks—12 weeks prematurely. Her rocket ship scar, and a few other small ones, are marks left by lines inserted into... Read more
The Ventilation Technology From Getinge That Is Groundbreaking Both For Premature Babies And Adults
2020 30 Sep
Born 12 weeks too early with a 50/50 chance at survival, Sabina Checketts has grown up to become a neonatal doctor herself, using new therapies and sophisticated technology to improve outcomes for premature babies. One such technique called NAVA, invented by Getinge, utilizes sensors to help babies on ventilators breathe more easily and naturally—and... Read more
RCT shows that NAVA shortens time of mechanical ventilation by almost 35% for adult ICU patients
2020 30 Sep
The clinical effectiveness of Getinge ’s patented Neurally Adjusted Ventilatory Assist (NAVA), which uses the patient’s own respiratory drive to control ventilator assistance, is supported in the NAVIATOR trial. According to the NAVIATOR trial, NAVA significantly increased the number of ventilator-free days and shortened the time of mechanical ventilation... Read more
NAVIATOR Trial: NAVA Shortens Time Of Mechanical Ventilation By Almost 35% For Adult ICU Patients
2020 30 Sep
The clinical effectiveness of Getinge’s patented Neurally Adjusted Ventilatory Assist (NAVA), which uses the patient’s own respiratory drive to control ventilator assistance, is supported in the NAVIATOR trial. According to the NAVIATOR trial, NAVA significantly increased the number of ventilator-free days and shortened the time of mechanical ventilation... Read more